Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer T cell stimulants are primarily glycolipid antigens that activate invariant NK-TCR-expressing lymphocytes via presentation on CD1d molecules. This leads to rapid secretion of diverse cytokines that shape both innate and adaptive immunity—making these pathways important targets for therapeutic intervention across cancer immunotherapy, infectious disease control, autoimmunity modulation, and allergy management.
Activation of NKT cells via TCR binding to CD1d-presented glycolipid antigens, leading to cytokine release.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer T Cell Stimulants (NKT Cell Stimulants).